{"id":38584,"date":"2024-12-04T06:00:03","date_gmt":"2024-12-04T05:00:03","guid":{"rendered":"https:\/\/eolog.com\/collaboration-and-operational-trial-agreement-with-msc-and-cargill\/"},"modified":"2024-12-04T06:00:03","modified_gmt":"2024-12-04T05:00:03","slug":"collaboration-and-operational-trial-agreement-with-msc-and-cargill","status":"publish","type":"post","link":"https:\/\/eolog.com\/en\/collaboration-and-operational-trial-agreement-with-msc-and-cargill\/","title":{"rendered":"Collaboration and Operational Trial Agreement with MSC and Cargill"},"content":{"rendered":"

<\/p>\n

[By: Quadrise]<\/p>\n

Quadrise Plc (AIM: QED)<\/a>, the supplier of innovative energy solutions for a cleaner planet, is delighted to announce the signature of a Collaboration and Operational Trial Agreement (the "Project Agreement") with MSC Shipmanagement Ltd ("MSC")<\/a> and Cargill NV ("Cargill")<\/a>, paving the way for the long-awaited vessel trials on board the MSC Leandra (the "Trials").<\/p>\n

Further to the Company's announcement of 10 July 2024, and under the Project Agreement, Quadrise, MSC and Cargill have agreed their respective obligations under which the Company's fuels, bioMSAR™ and MSAR®, will be produced at the MAC2<\/sup> facility in Antwerp, Belgium using feedstocks supplied by Cargill and then sold by Cargill to MSC for the Trials.<\/p>\n

The parties to the Project Agreement will use their reasonable endeavours to contribute towards the successful Trials and to receipt of a final Letter of No Objection from Wärtsilä following 4,000 hours of bioMSAR™ testing, with:<\/p>\n